Engineering Viruses to Treat Solid Tumors... Dr. Paul Peter Tak, CEO of Candel Therapeutics

Dr. Paul Peter Tack, CEO of Candel Therapeutics, unveils their groundbreaking approach to cancer treatments using engineered viruses. Discover how these viruses are harnessed to target solid tumors, deliver therapeutic genes, and activate the patient's immune system for a powerful anti-cancer response.